Hydrolytic biotransformation of the bumetanide ester prodrug DIMAEB to bumetanide by esterases in neonatal human and rat serum and neonatal rat brain : A new treatment strategy for neonatal seizures?

Zur Kurzanzeige

dc.identifier.uri http://dx.doi.org/10.15488/10679
dc.identifier.uri https://www.repo.uni-hannover.de/handle/123456789/10757
dc.contributor.author Theilmann, Wiebke
dc.contributor.author Brandt, Claudia
dc.contributor.author Bohnhorst, Bettina
dc.contributor.author Winstroth, Anne-Mieke
dc.contributor.author Das, Anibh Martin
dc.contributor.author Gramer, Martina
dc.contributor.author Kipper, Andi
dc.contributor.author Kalesse, Markus
dc.contributor.author Löscher, Wolfgang
dc.date.accessioned 2021-03-30T06:51:17Z
dc.date.available 2021-03-30T06:51:17Z
dc.date.issued 2021
dc.identifier.citation Theilmann, W.; Brandt, C.; Bohnhorst, B.; Winstroth, A.-M.; Das, A.M. et al.: Hydrolytic biotransformation of the bumetanide ester prodrug DIMAEB to bumetanide by esterases in neonatal human and rat serum and neonatal rat brain : A new treatment strategy for neonatal seizures?. In: Epilepsia 62 (2021), Nr. 1, S. 269-278. DOI: https://doi.org/10.1111/epi.16746
dc.description.abstract Objectives: The loop diuretic bumetanide has been proposed previously as an adjunct treatment for neonatal seizures because bumetanide is thought to potentiate the action of γ--aminobutyric acid (GABA)ergic drugs such as phenobarbital by preventing abnormal intracellular accumulation of chloride and the subsequent "GABA shift." However, a clinical trial in neonates failed to demonstrate such a synergistic effect of bumetanide, most likely because this drug only poorly penetrates into the brain. This prompted us to develop lipophilic prodrugs of bumetanide, such as the N,N-dimethylaminoethyl ester of bumetanide (DIMAEB), which rapidly enter the brain where they are hydrolyzed by esterases to the parent compound, as demonstrated previously by us in adult rodents. However, it is not known whether esterase activity in neonates is sufficient to hydrolyze ester prodrugs such as DIMAEB. Methods: In the present study, we examined whether esterases in neonatal serum of healthy term infants are capable of hydrolyzing DIMAEB to bumetanide and whether this activity is different from the serum of adults. Furthermore, to extrapolate the findings to brain tissue, we performed experiments with brain tissue and serum of neonatal and adult rats. Results: Serum from 1- to 2-day-old infants was capable of hydrolyzing DIMAEB to bumetanide at a rate similar to that of serum from adult individuals. Similarly, serum and brain tissue of neonatal rats rapidly hydrolyzed DIMAEB to bumetanide. Significance: These data provide a prerequisite for further evaluating the potential of bumetanide prodrugs as add-on therapy to phenobarbital and other antiseizure drugs as a new strategy for improving pharmacotherapy of neonatal seizures. © 2020 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy eng
dc.language.iso eng
dc.publisher Oxford [u.a.] : Wiley-Blackwell
dc.relation.ispartofseries Epilepsia 62 (2021), Nr. 1
dc.rights CC BY-NC 4.0 Unported
dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/
dc.subject blood-brain barrier eng
dc.subject BUM5 eng
dc.subject carboxylesterase eng
dc.subject NKCC1 eng
dc.subject ontogenesis eng
dc.subject phenobarbital eng
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title Hydrolytic biotransformation of the bumetanide ester prodrug DIMAEB to bumetanide by esterases in neonatal human and rat serum and neonatal rat brain : A new treatment strategy for neonatal seizures?
dc.type Article
dc.type Text
dc.relation.essn 1528-1167
dc.relation.issn 0013-9580
dc.relation.doi https://doi.org/10.1111/epi.16746
dc.bibliographicCitation.issue 1
dc.bibliographicCitation.volume 62
dc.bibliographicCitation.firstPage 269
dc.bibliographicCitation.lastPage 278
dc.description.version publishedVersion
tib.accessRights frei zug�nglich


Die Publikation erscheint in Sammlung(en):

Zur Kurzanzeige

 

Suche im Repositorium


Durchblättern

Mein Nutzer/innenkonto

Nutzungsstatistiken